Reaction
Selective Eating Disorder reporting signals
As of the last recalculation, Selective Eating Disorder appears in 899 FAERS reports alongside 25 co-occurring drug terms. The strongest observed disproportionality signal is DALTEPARIN SODIUM (PRR 56.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Dalteparin Sodium | 25 | 56.3 | 56.4 |
| Venlafaxine | 122 | 45.5 | 45.6 |
| Asenapine Maleate | 15 | 40.7 | 40.8 |
| Lamotirigine | 99 | 35.8 | 35.9 |
| Lamotrigine Extended-Release | 99 | 35.8 | 35.9 |
| Lamotrigine Chewable Dispersible | 99 | 35.8 | 35.9 |
| Aripiprazole Oral | 44 | 25.9 | 25.9 |
| Aripiprazole Orally Disintegrating | 44 | 25.9 | 25.9 |
| Venlafaxine Hydrochloride | 127 | 25.7 | 25.7 |
| Lamotrigine | 122 | 24.6 | 24.7 |
| Misoprostol | 10 | 24.0 | 24.1 |
| Clobazam | 24 | 23.4 | 23.4 |
| Buprenorphine Hydrochloride, Naloxone Hydrochloride | 22 | 21.6 | 21.6 |
| Levetiracetam In Sodium Chloride | 66 | 21.2 | 21.2 |
| Levetiracetam Oral | 66 | 21.2 | 21.2 |
| Levetiracetam Injection | 66 | 21.2 | 21.2 |
| Phenytoin | 17 | 19.2 | 19.2 |
| Fondaparinux Sodium | 6 | 17.3 | 17.3 |
| Guanfacine | 5 | 14.8 | 14.8 |
| Asfotase Alfa | 6 | 14.0 | 14.0 |
| Ziprasidone | 10 | 13.3 | 13.3 |
| Levetiracetam | 68 | 12.7 | 12.7 |
| Palivizumab | 8 | 12.2 | 12.2 |
| Nicotine Polacrilex | 15 | 9.2 | 9.2 |
| Lumacaftor And Ivacaftor | 3 | 8.1 | 8.1 |